Liviro3 recall
This article was originally published in The Tan Sheet
Executive Summary
Los Angeles-based Ebek says Jan. 19 it is issuing a voluntary nationwide recall of its supplement Liviro3 because the product contains tadalafil (Cialis), which is used to treat erectile dysfunction. Therefore, FDA says the product is an unapproved drug. FDA advised Ebek to recall the product because tadalafil may interact with nitrates found in prescription drugs and may lower blood pressure to dangerous levels. No illnesses have been reported to the company. In July 2006 an FDA survey found seven dietary supplements marketed to treat ED contained illegal drugs due to adulteration with active ingredients used in Rx ED treatments (1"The Tan Sheet," July 17, 2006, p. 4)...